Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
11,037 total articles
SoundHound AI is showing tangible signs of margin improvement and durable revenue growth driven by automotive assistants and restaurant automation. The stock remains beaten down from 2025 highs, offering a high-risk, high-reward long trade with a clear entry, stop and $12 target tied to improving operating leverage and multiple expansion if revenue…
Carlsberg (CABGY) trades near $25.54 after a pullback from its $32.16 52-week high. The stock offers a roughly 2.36% dividend yield, a market cap of about $17.4B and a trailing P/E of 18.6. We recommend a swing long that captures mean-reversion toward the $30 area while limiting downside via a stop near the 52-week low.
Microsoft is cheaper than it has been in years on a P/E in the low-20s, technicals are forming a base, and AI infrastructure spend is a two-sided bet the market is punishing too harshly. This is a mid-term swing trade: enter near $369.65, stop $349.00, target $420.00 over ~45 trading days.
AST SpaceMobile trades like a story stock with meaningful liquidity and sector catalysts. Its plan to deliver direct-to-phone broadband is unique, and recent sector tailwinds have pushed the stock near its 52-week high. Valuation is very rich, and operational cash burn is real - but momentum, cash per share, and a narrow short-covering runway creat…
Lightbridge's next-generation nuclear fuel tech is entering visible technical and IP milestones while the stock trades near $10 with a market cap of ~$343M and $238M in cash. The risk/reward favors a long exposure for patient traders who can tolerate regulatory, commercial and execution risk. This trade idea lays out an entry, stop and target for a…
VanEck Gold Miners ETF (GDX) pulled back into its short-term averages after a powerful run. Macro tailwinds for gold remain intact and recent options/put-call commentary points to an upside bias. This trade idea lays out an entry at $94.17, a stop at $88.00 and a primary target of $102.00 for a swing trade over the next 45 trading days, with a seco…
FedEx is scaling a higher-margin mix while squeezing more capacity out of a reworked network. With free cash flow of $4.37B, a market cap near $85.8B and a reasonable multiple (P/E ~19, EV/EBITDA ~10.1), the stock offers an attractive risk/reward for a long trade targeting a retest of and modestly exceeding the 52-week high. Entry, stop and target …
AppLovin (APP) has been punished in 2026, but the company's core ad platform momentum, profitable economics and a $140B enterprise footprint argue the downside is limited. This trade targets a recovery to $550 over the next 180 trading days with a disciplined stop at $360.
Advanced Micro Devices is trading at $221 and carries the premium of an AI compounder, but several near-term catalysts - new Venice CPU adoption, strategic inference deals with hyperscalers, and improving cash flow - are underappreciated by the market. This trade targets a re-rate toward $260 over the next 45 trading days while containing downside …
Lantheus (LNTH) faces a near-term tug-of-war: a valuable radiodiagnostics franchise and clean balance sheet versus compressed sales momentum for PYLARIFY and an apparent regulatory slip that extended a PDUFA timetable. The stock sits near $75.87 with a market cap around $4.9B and a P/E in the low-20s. For traders willing to accept elevated executio…
Pearson (PSO) looks positioned to re-rate as operating leverage from Virtual Learning, Workforce Skills, and Assessment expands. Technical indicators show bullish momentum, valuation is grounded at a $8.21B market cap and a 19.7x P/E, and the AI/EdTech backdrop is a multi-year tailwind. This trade targets a move toward the $16 area over the next 18…
Anthropic's reported $30 billion ARR is a structural shock to the AI market. That level of scale threatens Microsoft’s AI premium in Azure and Copilot-led monetization, compresses long-term margin expectations, and increases the chance of revenue share and pricing pressure. We downgrade Microsoft and lay out a short-biased trade for a mid-term hori…
Encompass Health (EHC) offers a compelling risk-reward as an operationally efficient post-acute care provider trading at reasonable multiples. With $439M in annual free cash flow, a market cap near $10.45B, and ROE above 23%, the equity can grow into its valuation via modest revenue expansion, margin stability, and continued buybacks/dividends. Leg…
BigBear.ai (BBAI) has repositioned itself through acquisitions and balance-sheet repairs, but revenue compression and sustained losses keep the stock volatile. For traders willing to accept execution risk, a disciplined long swing trade captures upside from contract catalysts and integration progress while limiting downside with a tight stop.
Palantir sits at an awkwardly valuable intersection: deep government footing, expanding enterprise platform adoption, and a product roadmap increasingly aligned with business AI deployments. The trade is a directional long that leans on durable customer relationships and accelerating AI monetization, balanced by concentration and execution risk.
Energy Transfer (ET) remains a high-yield, fee-based midstream operator trading at reasonable multiples. With a market cap near $65B, an attractive dividend yield (~6.99%), and valuation metrics like P/E ~15.6 and EV/EBITDA ~8.8, ET offers a favorable risk-reward for income-oriented traders. This piece lays out an actionable trade: entry, stop, tar…
FuboTV is cheap on revenue multiples, carries meaningful operational risk but also a concentrated short position and improving momentum. This trade idea lays out a clear entry at $12.65, a stop at the 52-week low $8.31, and a $20 target over a 180-trading-day horizon.
One Stop Systems (OSS) is a micro-cap supplier of rugged, GPU-accelerated compute and storage for defense, aerospace, and commercial edge AI. Recent design wins and platform awards give the stock a clear near-term revenue runway; balance-sheet strength and no debt reduce bankruptcy risk, but small revenue and negative free cash flow keep execution …
AIRO Group ($8.79) is an undervalued small-cap play on the rising Drone-as-a-Service (Daas) market. The company offers avionics and autonomy technology with a clean balance sheet, positive free cash flow and an enterprise value of roughly $203.5M. With the Daas market expanding and short interest elevated, a disciplined long trade targets a near-te…
Vistra is positioned to be a structural beneficiary of rising baseload demand from AI data centers and corporate PPAs. The company’s scale (about 44 GW of capacity and roughly 5 million retail customers) plus recent long-term contracts with hyperscalers create a visible growth runway. Balance sheet and regulatory risks remain, but a measured long t…
Veeva Systems (VEEV) looks attractive after a material pullback. The shares trade near $175 with a c.$28.5B market cap, clean balance sheet and meaningful free cash flow. Management's $2B buyback, durable switching costs in life sciences and AI-driven product expansion support upside into the next several quarters. This trade idea lays out an entry…
UnitedHealth jumped after CMS raised Medicare Advantage payment rates. The move materially improves near-term revenue and margin outlook for UnitedHealthcare and feeds Optum volume growth. With a market cap near $255B, a 21x P/E and $16B in free cash flow, UNH looks attractively positioned for a mid-term swing trade. Entry $295, stop $275, target $…
Okta is a market-leading identity platform trading at a $14.3B market cap with measurable cash generation and improving momentum in product-led AI security. Recent results show decelerating but profitable growth; I view current levels as an actionable long with a clear entry, stop, and target tied to renewed ARR expansion and multiple expansion if …
Bowman (BWMN) has been busy building a utility-focused platform via acquisitions while organic end-markets - utilities, data centers and federal surveying - are expanding. At roughly $29.60 and a market cap near $506M, the stock trades at modest multiples for a company that just reported $122.1M in a quarter and is generating meaningful free cash f…
KalVista's oral HAE drug Ekterly produced $1.4M in Q1 FY2026 sales and the company has transitioned to commercial operations. The shares trade around $20 with a market cap near $1.03B, but technicals and mounting short interest set the stage for a mid-term swing. This trade idea targets continued uptake over the next ~45 trading days while protecti…
